Among the last ones, we can mention that inhibition of galectin-1 or galectin-3 both potentiates tumor cell sensitivity to several types of chemotherapies (involving different molecular mechanisms) in a panoply of different cancers [315,316,317,318,319,320,321,322,323,324,325,326,327,328,329,330,331,332,333,334,335]. The gene discussed is LGALS1; the disease is neoplasm.